BPC-157 + TB-500 Blend 10mg / 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of BPC-157/TB-500 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic, spectrometric and mass spectrometry techniques. Batch: GF-BPCTB10-B241 Key analytical results include:

• BPC-157 Assay Content: 16.04 mg
• BPC-157 Identification by RT: 0.993
• BPC-157 Purity: greater than 99.8 percent
• BPC-157 Molecular Ion Mass Identification: 1418 Da
• TB-500 Assay Content: 13.44 mg
• TB-500 Identification by RT: 0.999
• TB-500 Purity: 99.6 percent
• TB-500 Molecular Ion Mass Identification: 4962 Da
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. These analytical procedures provide confirmation of identity, purity, batch consistency and laboratory-grade research quality.

Product Overview

BPC-157/TB-500 is a dual-peptide research formulation combining two extensively studied peptide compounds within a single laboratory preparation. The combination is frequently utilised in controlled research environments focused on peptide-mediated biological processes, cellular signalling pathways and molecular communication systems. The blend allows researchers to investigate multiple peptide mechanisms simultaneously while maintaining independently verified analytical specifications for each constituent peptide. This preparation contains high-purity lyophilized BPC-157 and TB-500 supplied in a sealed research vial. Lyophilization helps preserve peptide stability and allows researchers to reconstitute the material for controlled laboratory experimentation. Due to the extensive scientific interest surrounding both peptides individually, this combination has become a frequently referenced research preparation within peptide-related laboratory studies.

Peptide Overview

BPC-157 is a synthetic peptide widely studied in laboratory environments for its interaction with peptide-mediated signalling pathways and molecular regulatory systems. TB-500 is a synthetic form of Thymosin Beta 4 and is frequently investigated within experimental models examining cellular signalling mechanisms and peptide-regulated biological processes. Together, these compounds provide researchers with a dual-peptide model suitable for studying complex signalling networks and peptide interaction dynamics within controlled research environments. The defined molecular structures of both peptides and their extensive presence within scientific literature have contributed to their popularity within peptide research.

Historical Background and Scientific Context

Scientific interest in peptide-mediated biological regulation expanded considerably during the late twentieth century as advances in molecular biology enabled researchers to identify increasingly complex signalling systems. BPC-157 and Thymosin Beta 4 emerged as important subjects of investigation due to their unique peptide structures and broad relevance within experimental biological research. Continued advances in peptide synthesis and analytical verification technologies have enabled researchers to investigate these compounds with increasing precision under controlled laboratory conditions. Today, both peptides remain widely referenced throughout peptide research literature and laboratory investigations.

Mechanistic Focus in Research

Within controlled laboratory settings, BPC-157/TB-500 is commonly studied in relation to peptide-mediated signalling networks and cellular regulatory mechanisms. Research investigations frequently explore the blend in experimental models examining:

• Peptide signalling pathways
• Cellular communication systems
• Molecular regulatory mechanisms
• Intracellular signalling cascades
• Peptide interaction dynamics
• Comparative peptide research models
• Multi-peptide signalling analysis

These experimental approaches allow researchers to investigate complex biological processes associated with peptide-mediated regulation and signalling.

Research Applications

In controlled research environments, BPC-157/TB-500 may be utilised in experimental models designed to investigate peptide signalling systems and molecular regulatory pathways. Examples of research applications include:

• Peptide interaction studies
• Cell signalling pathway investigations
• Molecular pathway analysis
• Comparative peptide research
• Cellular communication modelling
• Multi-peptide signalling studies
• Controlled in vitro peptide experiments

These applications are conducted exclusively within laboratory environments and are intended to improve scientific understanding of peptide-mediated biological processes.

Grail Formula Quality

Every Grail Formula research compound is produced and handled according to strict quality standards designed to support reliable laboratory experimentation. Each batch undergoes comprehensive independent analytical testing to verify:

• Peptide identity confirmation
• Assay content verification
• Purity confirmation
• Molecular mass verification
• Microbial safety screening
• Endotoxin analysis
• Heavy metal screening
• Full batch traceability

Independent laboratory verification provides researchers with transparent analytical data and confidence in the consistency of the supplied research material.

When You Choose Grail Formula

When selecting Grail Formula, researchers gain access to independently verified research compounds supported by extensive analytical documentation and batch-specific testing. Our commitment to transparency includes publication of assay results, purity verification, identity confirmation, endotoxin testing, microbial screening, elemental impurity analysis and molecular mass verification. Every batch is supported by a downloadable Certificate of Analysis, providing full traceability and independent verification from Liquilabs s.r.o. Czechia.

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• BPC-157 purity greater than 99.8 % confirmed by COA
• TB-500 purity 99.6 % confirmed by COA
• Assay content verified at 16.04 mg BPC-157 and 13.44 mg TB-500
• Molecular ion masses identified at 1418 Da and 4962 Da
• Endotoxin level below 0.001 EU/mg
• No detectable heavy metals or microbial contamination
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.